NASDAQ · Biotechnology

Bambusa Therapeutics Inc. (BBTX) Stock Price & Fundamentals

$16.21 +0.76% NASDAQ: BBTX Healthcare

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company.

Valuation

MetricValue
Price$16.21
Market Cap$806.74M
P/E Ratio—
P/B Ratio—
P/S Ratio—
EPS (TTM)—
52-Week High$17.65
52-Week Low$13.60
Dividend Yield—

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity—
Current Ratio6.16

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $348.51 -0.62% 38.68 $5.06T 0.31%
VRTXVertex Pharmaceuticals Incorporated $535.90 -0.50% 34.56 $135.87B 0.00%
REGNRegeneron Pharmaceuticals, Inc. $955.15 -0.03% 19.22 $98.79B 0.47%
MRNAModerna, Inc. $215.00 -3.75% — $86.99B 0.00%
RVMDRevolution Medicines, Inc. $168.19 -2.38% — $36.38B 0.00%
ROIVRoivant Sciences Ltd. $39.35 -0.46% — $28.51B 0.00%
INSMInsmed Incorporated $124.24 +2.55% — $27.26B 0.00%
UTHRUnited Therapeutics Corporation $585.89 -0.89% 21.31 $24.95B 0.00%

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield—
Quick Ratio5.95
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held31.57%
Institutions Held32.60%
Institutions Float Held47.63%

For Bambusa Therapeutics Inc., insiders hold 31.57% of the shares, institutions hold 32.60%, according to the latest holder filings.

Filings & documents

Bambusa Therapeutics Inc. (BBTX) reports filed with the US Securities and Exchange Commission, newest first. SEC CIK 0002044950. Links open sec.gov.

Recent events (8-K)

  • Charter or bylaw amendment; Regulation FD disclosure8-K

Source: SEC EDGAR, checked 16 Nov 2026. All filings on SEC EDGAR

Latest News

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering PR Newswire · Oct 30, 2026

About Bambusa Therapeutics Inc.

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.

Bambusa Therapeutics Inc. is headquartered in US.

Bambusa Therapeutics Inc. (BBTX) stock trades at $16.21 with a market capitalization of $806.74M. Over the past 52 weeks the stock has ranged between $13.60 and $17.65, and currently trades 8.2% below its 52-week high.

Official website: www.bambusatx.com

Bambusa Therapeutics Inc. (BBTX) — frequently asked questions

What is Bambusa Therapeutics Inc. (BBTX) stock price today?

Bambusa Therapeutics Inc. (BBTX) is currently trading at $16.21, up 0.76% today.

What is Bambusa Therapeutics Inc.'s market cap?

Bambusa Therapeutics Inc. has a market capitalization of $806.74M.

What is BBTX's profit margin?

Bambusa Therapeutics Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.

What sector is BBTX in?

Bambusa Therapeutics Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is BBTX listed on?

Bambusa Therapeutics Inc. trades on NASDAQ under the ticker BBTX.

What is BBTX's 52-week range?

Over the last year Bambusa Therapeutics Inc. has traded between $13.60 and $17.65.

Related Healthcare Stocks

VRTX Vertex Pharmaceuticals Incorporated $535.90 -0.50% REGN Regeneron Pharmaceuticals, Inc. $955.15 -0.03% MRNA Moderna, Inc. $215.00 -3.75% RVMD Revolution Medicines, Inc. $168.19 -2.38% ROIV Roivant Sciences Ltd. $39.35 -0.46% INSM Insmed Incorporated $124.24 +2.55% UTHR United Therapeutics Corporation $585.89 -0.89% INCY Incyte Corporation $120.77 -0.17% ALNY Alnylam Pharmaceuticals, Inc. $161.68 -2.03% ASND Ascendis Pharma A/S - Ordinary Share $272.12 -1.19% EXEL Exelixis, Inc. $67.81 -1.73% NBIX Neurocrine Biosciences, Inc. $167.08 -0.19%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens BBTX currently matches

On the figures above, Bambusa Therapeutics Inc. passes the filters for 4 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksStocks Under $100Stocks Under $50High Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.